𝔖 Bobbio Scriptorium
✦   LIBER   ✦

GD3-reactive antibodies can inhibit the lysis of autologous tumor cells by tumor-infiltrating lymphocytes

✍ Scribed by Edward B. Reilly; Giovanna Antognetti

Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
454 KB
Volume
35
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lysis by interleukin 2-stimulated tumor-
Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells
✍ Marina Radrizzani; Carlo Gambacorti-Passerini; Giorgio Parmiani; Giuseppe Fossat 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 777 KB

Peripheral blood lymphocytes (PBL) and tumor-infiltrating lymphocytes (TIL) were isolated from six cancer patients and cultured in the presence of 100 units/ml of recombinant interleukin 2 (IL2). Both IL2-stimulated PBL (IL2-PBL) and IL2-stimulated TIL (IL2-TIL) lysed fresh and short-term cultured a

Lysis of autologous tumor cells by blood
Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery
✍ Farkas Vánky; Eva Klein; Jan Willems; Kim Böök; Torbjörn Ivert; Arpád Péterffy; 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 569 KB

Lymphocyte-mediated lysis of autologous tumor cells (autologous lymphocyte cytotoxocity ALC) was tested at the time of surgery in 108 patients (46 squamous cell carcinomas of the lung, 25 adenocarcinomas of the lung, 19 soft tissue sarcomas and 18 osteosarcomas). The clinical course of these patient

Efficient tumor cell lysis by autologous
Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody
✍ Pauline Wimberger; Wei Xiang; Doris Mayr; Joachim Diebold; Torsten Dreier; Patri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB

## Abstract The epithelial cell adhesion molecule (Ep‐CAM) is expressed on the surface of most human carcinomas, including ovarian, breast, lung, prostate and colorectal carcinoma. Ep‐CAM was shown to be a valid target for monoclonal antibody‐based therapies. We have investigated whether an Ep‐CAM‐

Lysis of tumor cells by the retargeting
Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies
✍ I. G. Barr; H. R. Macdonald; F. Buchegger; V. Von Fliedner 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 652 KB

The specificity and efficiency of tumor-cell lysis by the retargeting of murine cytolytic lymphocytes (CTL) with bispecific antibodies was examined. Bispecific antibodies (also known as heteroaggregated or hybrid antibodies) were produced by the chemical coupling of monoclonal antibodies (MAbs) agai